SLMBP Q1 2026 Earnings EPS Surges Past Expectations as Loan Portfolio Strengthens Passage Bio Q1 2026 Earnings Narrowerthanexpected loss signals disciplined spending TCRT Q4 2023 Earnings EPS Miss as PreRevenue Biotech Reports Operational Progress FFIN Q1 2026 Earnings EPS Beats Estimates by 38 VSEC Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction RenovoRx Inc RNXT Q1 2026 Earnings Wider Loss Per Share Amid PreRevenue ClinicalStage Operations